Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1novo-nordiskglp-1pipelineobesity

Novo Nordisk Exits Another Monthly GLP-1 Programme

FirstWord Pharma reports the Danish drugmaker has dropped a further long-acting monthly GLP-1 candidate from its pipeline.

MH
By Maren Holt · Senior Reporter, GLP-1
Sep 15 17:44 ETSource: FirstWord PHARMA

The wire

  1. 01Novo Nordisk discontinued another monthly-dosing GLP-1 programme.
  2. 02Signals narrowing of Novo's long-interval dosing ambitions amid intense obesity drug competition.
  3. 03Reasons for the exit and remaining pipeline plans are not detailed.

From the source

Novo exits another monthly GLP-1 programme

Read at news.google.com
Source URL https://news.google.com/rss/articles/CBMiU0FVX3lxTE95YllTSFdXZ1czS2JfVTlnMnpYNUZyN0RiRmQtbHprS2lGNktSazJ1MndLUi1XRG4xZUkybmpobjR0eDh0elZydzllTTg3ZWJTcXBN?oc=5